Does Ginkgo help blood sugar? (Grade C evidence)
For blood sugar, Ginkgo sits at Grade C — a hint of benefit in limited trials, especially in adults with metabolic risk factors, low certainty, at doses varies across trials.
Bottom line. For blood sugar, Ginkgo sits at Grade C — a hint of benefit in limited trials, especially in adults with metabolic risk factors, low certainty, at doses varies across trials. [1 RCT]
- Direction
- benefit
- Magnitude
- Meta-analysis: Ginkgo biloba extract significantly reduced fasting blood glucose and improved insulin resistance (HOMA-IR) versus control, plus reduced BMI and waist circumference, but did NOT significantly change HbA1c or fasting insulin levels — a partial biomarker signal, not comprehensive glycemic control.
- Grade
- C
- Certainty
- low
- Clinical meaning
- small but potentially useful
- Who it applies to
- adults with metabolic risk factors
- Dose / form studied
- Safety
- serious_with_warfarin; moderate_with_ssri
- The one limitation
- Sample sizes are small in most included trials; effect sizes may shrink with larger studies.
Reviewed · Evidence last changed · Claim clm_ec_b9-ginkgo-blood-sugar v1
⚠ Safety in context
- seriouswith Warfarin: Ginkgo has antiplatelet activity; with warfarin it may increase bleeding risk. full interaction →
- moderatewith SSRI: Possible additive bleeding/serotonergic effects with SSRIs. full interaction →
Grade C / low: hints of benefit in small trials; a well-run RCT could easily push this to B or to null.
Who it works for
Best-studied in adults with metabolic risk factors. Effective doses cluster around varies across trials.
Evidence
| Study | Design | Cite |
|---|---|---|
| Effects of Ginkgo biloba extract on glycemic control, inflammatory markers, lipid profile, anthropometric indices, and safety parameters in patients with metabolic syndrome and type 2 diabetes: a meta-analysis. | peer-reviewed | PMID:42157337 |
Why this grade
Reasoning trace
Grade C at low certainty. The grade reflects the direction and size of the effect across the 1 publishable source above; certainty reflects heterogeneity, sample sizes, and design quality. What would move it upward: additional well-powered RCTs in the target population that replicate the effect at similar doses. What would move it down: a large null trial, discovery of publication bias, or a retraction of a keystone study.
Dose & form
Studied intake: varies across trials.
How it stacks up for blood sugar
- Ginkgo vs Berberine for blood sugar — Berberine Grade B
- Ginkgo vs Magnesium for blood sugar — Magnesium Grade C
- Ginkgo vs Myo-Inositol for blood sugar — Myo-Inositol Grade B
- Ginkgo vs Ashwagandha for blood sugar — Ashwagandha Grade C
- Ginkgo vs Omega-3 for blood sugar — Omega-3 Grade B
- Ginkgo vs Creatine for blood sugar — Creatine Grade C
- All interventions graded for blood sugar →
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 6 months (Grade C+) — next review by . Methodology v1.
Re-review cadence: every 6 months (Grade C+) · next scheduled by · methodology v1.
Frequently asked
How long does Ginkgo take to work for blood sugar?
Trials of Ginkgo for blood sugar typically report effects within 2–4 weeks, though individual response varies. Studies rarely find benefit inside 1 week for chronic outcomes.
What dose was used in studies of Ginkgo for blood sugar?
Studied doses for Ginkgo in blood sugar trials cluster around varies across trials. See the dose block for the specific range and how it varies by form.
Does Ginkgo work for blood sugar if I'm not deficient?
The effect concentrates in adults with metabolic risk factors. If your baseline is normal, expect a smaller effect than the trial averages.
Ginkgo or the next-best alternative for blood sugar?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- Meta-analysis: Ginkgo biloba extract significantly reduced fasting blood glucose and improved insulin resistance (HOMA-IR) versus control, plus reduced BMI and waist circumference, but did NOT significantly change HbA1c or fasting insulin levels — a partial biomarker signal, not comprehensive glycemic control.
- Substrate's interpretation
- Grade C at low certainty — the direction and size the studies converge on, as our reading of the corpus.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Reuse under CC-BY 4.0 with attribution to evidencebased.info.
Plain-text citation
Substrate. Does Ginkgo help blood sugar? (Grade C). https://evidencebased.info/interventions/ginkgo/blood-sugar. Updated 2026-07-16.
BibTeX
@misc{substrate_ionsginkgobloodsugar,
author = {Substrate editorial},
title = {Does Ginkgo help blood sugar?},
year = {2026},
url = {https://evidencebased.info/interventions/ginkgo/blood-sugar},
note = {Grade C, evidencebased.info}
}Found something wrong on this page? Report an error →